GB899219A - Steroid compounds - Google Patents
Steroid compoundsInfo
- Publication number
- GB899219A GB899219A GB44786/60A GB4478660A GB899219A GB 899219 A GB899219 A GB 899219A GB 44786/60 A GB44786/60 A GB 44786/60A GB 4478660 A GB4478660 A GB 4478660A GB 899219 A GB899219 A GB 899219A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acyloxy
- hydroxy
- testosterone
- methyl
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Abstract
The invention comprises steroid compounds of the general formula <FORM:0899219/IV (b)/1> wherein X represents hydrogen or bromine or X is not present when there is a 1,2-double bond, Y represents hydrogen when X represents bromine or is not present, chlorine when X represents hydrogen or bromine, or Y is not present when there is a 6,7 double bond and when X represents hydrogen or is not present, and R represents hydrogen or the acyl residue of a carboxylic acid containing not more than 9 carbon atoms; and processes for the preparation of: 2a -bromo-4-hydroxy(or acyloxy)-17a -methyltestosterone or 2a - bromo - 6 - chloro - 4 - hydroxy (or acyloxy) - 17a - methyl - testosterone by brominating the corresponding 4-hydroxy-(or acyloxy) - 17a - methyl - testosterone with bromine or with N-bromosiccinimide in an organic halogenated solvent such as carbon tetrachloride, chloroform, methylene chloride or acetic acid; 2a -bromo-6b -chloro-4-hydroxy (or acyloxy)-17a -methyl-testosterone or 6b -chloro-4-hydroxy (or acyloxy)-17a -methyl-testosterone by chorinating the corresponding 4-hydroxy-(or acyloxy)-17a -methyl-testosterone with chlorine or with N-chlorosuccinimide in an organic halogenated solvent such as carbon tetrachloride chloroform or methylenechloride; 2a -bromo-6a -chloro-4-hydroxy (or acyloxy)-17a -methyl-testosterone- or 6a -chloro-4-hydroxy (or acyloxy)-17a -methyl-testosterone by chlorinating the corresponding 4-hydroxy(or acyloxy)-17a -methyl-testosterone with chlorine or with N-chlorosuccinimide in acetic acid; 1, 2 - dehydro - 4 - hydroxy (or acyloxy) - 17a - methyl-testosterone by treating 2a -bromo-4-hydroxy (or acyloxy) - 17a - methyl - testosterone with lithium bromide and lithium carbonate at 80 DEG C. to 110 DEG C. for 10 to 30 hours or by dehydrogenating 4 - hydroxy (or acyloxy) - 17a - methyl-testosterone with selenium dioxide in t-butanol; 6,7-dehydro-4-hydroxy (or acyloxy)-17a - methyl - testosterone by dehydrogenating 4-hydroxy (or acyloxy)-17a -methyl-testosterone with chloranil in warm toluene or by dehydrochlorinating 6-chloro-4-hydroxy (or acyloxy)-17a -methyl-testosterone; and 1,2 : 6,7-dehydro-4 - hydroxy (or p acyloxy) - 17a - methyl - testosterone by dehydrogenating 1,2-dehydro-4-hydroxy (or acyloxy)-17a -methyl-testosterone with chloranil in warm toluene, by dehydrogenating 6,7-dehydro - 4 - hydroxy (or acyloxy) - 17a - methyl -testosterone with selenium dioxide in t-butanol, or by dehydrohalogenating 2a -bromo-6-chloro-4-hydroxy (or acyloxy)-17a -methyl-testosterone with lithium-bromide, chloride and carbonate in dimethylformamide. In any of the above processes, the product may be treated to hydrolyse a 4-acyloxy group or to acylate a 4-hydroxy group. Therapeutic compositions useful for stimulating anabolism contain as the active ingredient one or more steroids of the above general formula and a solid or liquid diluent. The composition may be in the form of a tablet, powder, pill, elixir or capsule. Specification 848,288 is referred to.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT11160 | 1960-01-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB899219A true GB899219A (en) | 1962-06-20 |
Family
ID=11097795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB44786/60A Expired GB899219A (en) | 1960-01-04 | 1960-12-30 | Steroid compounds |
Country Status (7)
Country | Link |
---|---|
BE (1) | BE598785A (en) |
BR (1) | BR6125591D0 (en) |
CH (1) | CH409945A (en) |
DK (1) | DK115990B (en) |
ES (1) | ES263802A1 (en) |
FR (1) | FR833M (en) |
GB (1) | GB899219A (en) |
-
1960
- 1960-12-30 GB GB44786/60A patent/GB899219A/en not_active Expired
-
1961
- 1961-01-03 CH CH2061A patent/CH409945A/en unknown
- 1961-01-03 FR FR848653A patent/FR833M/fr active Active
- 1961-01-03 BE BE598785A patent/BE598785A/en unknown
- 1961-01-03 ES ES263802A patent/ES263802A1/en not_active Expired
- 1961-01-03 BR BR125591/61A patent/BR6125591D0/en unknown
- 1961-01-03 DK DK2061AA patent/DK115990B/en unknown
Also Published As
Publication number | Publication date |
---|---|
FR833M (en) | 1961-09-25 |
DK115990B (en) | 1969-12-01 |
BR6125591D0 (en) | 1973-05-29 |
CH409945A (en) | 1966-03-31 |
ES263802A1 (en) | 1961-06-16 |
BE598785A (en) | 1961-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2838501A (en) | 6-fluoro-11-oxygenated progesterones and process for preparing same | |
GB899219A (en) | Steroid compounds | |
GB951107A (en) | Improvements relating to a-nor-steroid compounds | |
US2694080A (en) | 11-hydroxy-13-methyl-17-(beta-hydroxyethylidene)-1, 2, 3, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16, 17-tetradecahydro-15h-cyclopenta[a]-phenanthren-3-one | |
Zalkow et al. | The Reaction of N-Bromosuccinimide with Bicyclo [2.2. 1]-5-heptene-endo-cis-2, 3-dicarboxylic Anhydride1 | |
GB946301A (en) | Novel steroids and process for their manufacture | |
US3462425A (en) | 6-halogeno-6-dehydro-3-keto-steroids | |
US3069435A (en) | Anabolically active 2-chlor-delta1-androsten-17-ol-3-ones and method of making same | |
US3299106A (en) | Process for the preparation of uncontaminated 17alpha-ethynyl-19-nor-delta4-androsten-17beta-ol-3-one | |
GB1004667A (en) | Improvements in or relating to steroids and the manufacture thereof | |
GB914795A (en) | 21-methyl steroids | |
US2857406A (en) | Derivatives of cortical hormones | |
GB971608A (en) | 17ª-methyl steroids and their production and use | |
GB923624A (en) | Steroid compounds | |
US2879277A (en) | 15 ketoprogesterones | |
US3600425A (en) | Synthesis of steroids | |
US3178416A (en) | 2beta, 19-oxido-5alpha-steroids and process therefor | |
US3068246A (en) | Process for the production of 1-dehydroprogesterone | |
GB933105A (en) | Steroid compounds | |
GB935116A (en) | New cyclopentanophenanthrene derivatives and processes for the production thereof | |
GB1084467A (en) | Improvements in or relating to steroids and the manufacture thereof | |
GB951474A (en) | Improvements in or relating to the bromination of steroid derivatives | |
GB854672A (en) | Preparation of 12ª‡-halo-16ª‡,17ª‡,21-trihydroxy-4-pregnene-3,11,20-triones and 16ª‡,21-acyl esters thereof | |
GB946578A (en) | Improvements in or relating to steroids and the manufacture thereof | |
GB1024812A (en) | Improvements in or relating to steroids and the manufacture thereof |